Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aristotelian University of Thessaloniki
Quinapril or losartan improved DAN and LVDD in asymptomatic patients with diabetes mellitus
April 8th, 2006
Early quinapril or losartan improved both diabetic autonomic neuropathy and left ventricular diastolic dysfunction in asymptomatic patients with type 1 or 2 diabetes mellitus, after 1 year of treatment. In a recently published article, scientists in Greece conducted a study "to investigate the effect of angiotensin converting enzyme inhibition (ACE-I) or angiotensin receptor blockade (ARB), and their combination, on both diabetic autonomic neuropathy (DAN) and left ventricular (LV) diastolic dysfunction (LVDD) in asymptomatic patients with diabetes mellitus (DM)." T.P. Didangelos and colleagues at Aristotelian University of Thessaloniki explained,...
Source: Law & Health Weekly (2006-04-08)
|
